Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

Updated KDIGO Guideline Recommends More Personalized Treatment for Anemia in Chronic Kidney Disease

The 2026 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD) calls for a more individualized approach to treatment, including tailored decisions on when to start anemia medications and preferred use of intravenous iron for patients receiving hemodialysis. A synopsis of the guideline highlighting the primary recommendations regarding the use of iron, erythropoiesis-stimulating agents (ESAs), and hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHI) is published in Annals of Internal Medicine.

September 14, 2026


September 15 2026

September 14 2026

September 11 2026

September 10 2026

September 9 2026

September 8 2026

September 7 2026

September 5 2026

September 4 2026

September 3 2026

September 2 2026

September 1 2026